The World Health Organisation (WHO) has issued new guidance on the ethics and governance of large multi-modal models (LMMs). The guidance details over 40…
- The European Commission launches an investigation into Chinese public procurement of medical devices
- Clinical Trials Agreements – How Much Flexibility is there for Sponsors Across the Globe?
- EU AI Act Approved by the EP – Update and Insight Into Other AI Industry Specific Developments
- New Emirates Drug Corporation Soon to be Operational Replacing MOHAP as Federal Regulator of all Medical Products
- The New EU Corporate Sustainability Due Diligence Directive Has Been Provisionally Agreed, What Does This Mean for H&LS Companies?
- Healthcare and AI: WHO Releases AI Guidance for Large Multi-Modal Models
- Key Legal Trends in The United States For Healthcare And Life Sciences In 2024
- MHRA Roadmap for Future UK Medical Device Legislation
In brief As we look back at 2023, we reflect on a year marked by significant developments in the legal framework governing the life…
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published a new roadmap setting out its timeline for an overhaul of the UK…
Today the European Commission has finally published its Proposal to revise the EU Pharmaceutical legislation, the most momentous…
On 26 April 2023 the European Commission published its Proposals to Reform the EU pharmaceutical legislation.[1] We continue…
In brief Reimbursing medicinal products is critical to ensure that treatments are widely available to patients. This is…
The Proposal to revise the EU Pharmaceutical legislation has generated unprecedented levels of attention, not only across the…
As previously covered in this blog, on 26 April 2023 the European Commission published a set of proposals…
As already well noted on this blog, on 26 April 2023 the European Commission published a set of…